SCHEMBL19506705

SCHEMBL19506705

CC(C)[C@@H]1O[C@H](C)[C@@H](O)[C@H](C)[C@H]1O

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19506707 0.86
SCHEMBL14257089 0.85 FUCA1 (0.34) FUCA1
SCHEMBL22796185 0.85 FUCA1 (0.34) FUCA1
SCHEMBL11954393 0.85 FUCA1 (0.34) FUCA1
SCHEMBL18767734 0.85 FUCA1 (0.34) FUCA1
SCHEMBL23478046 0.83 FUCA1 (0.38) FUCA1
SCHEMBL21946656 0.83 FUCA1 (0.38) FUCA1
SCHEMBL23640225 0.83 FUCA1 (0.38) FUCA1
SCHEMBL21116108 0.83 FUCA1 (0.38) FUCA1
SCHEMBL23478009 0.83 FUCA1 (0.38) FUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9982005-B2 Macrolides and methods of their preparation and use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-05-29 US disclosed
US-20170305953-A1 14-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305953-A1 14-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE CYP51A1, HSD17B7, CYP11B1 FUCA1 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.